Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New compounds with carborane showed anti-androgen effects similar to flutamide.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Glioblastoma cells can make androgens, which might help the tumor grow.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

New compounds were made that are promising for prostate cancer therapy.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.